Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.8M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
67.5M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$710M
-
Value change
-
+$26.8M
-
Put/Call ratio
-
0.91
-
Number of buys
-
90
-
Number of sells
-
-54
-
Price
-
$10.52
Significant Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q1 2024
184 filings reported holding ZYME - Zymeworks Inc. - Common Stock as of Q1 2024.
Zymeworks Inc. - Common Stock (ZYME) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.5M shares
of 74.8M outstanding shares and own 90.26% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (13.4M shares), BVF INC/IL (5.87M shares), Redmile Group, LLC (5.56M shares), MORGAN STANLEY (5.11M shares), BlackRock Inc. (4.1M shares), Rubric Capital Management LP (3.48M shares), VANGUARD GROUP INC (2.46M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.91M shares), CREDIT SUISSE AG/ (1.9M shares), and FARALLON CAPITAL MANAGEMENT LLC (1.6M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.